Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2010
10/20/2010EP2240472A1 2-amino-quinoline derivatives useful as inhibitors of -secretase (bace)
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2144897B1 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
10/20/2010EP2125794B1 Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
10/20/2010EP2038241B1 Electroluminescent polymers and use thereof
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1722798B1 Pyrimidine compounds as purine receptor antagonists
10/20/2010EP1569929B9 Compounds and methods for the treatment or prevention of flavivirus infections
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868455A Therapeutic substituted lactams
10/20/2010CN101868454A Cycloalkyloxy- and heterocycloalky-loxypyridine compounds as modulators of the histamine H3 receptor
10/20/2010CN101863923A Novel inhibitors of chymase
10/20/2010CN101863883A Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof
10/20/2010CN101863839A N-3-aramid-5-cyclopropane spiro hydantoin derivative, preparation method and application thereof
10/20/2010CN101863826A Method for preparing 2-benzyl pyridine compound
10/20/2010CN101863824A Synthesis method of chemical compound containing a dihydrogen ferrocenylmethyl-substituted indenes ketone and pyrrole skeleton
10/20/2010CN101302194B Synthetic method of polysubstituted chinoline compound
10/19/2010US7816673 Di-thieno-benzo-thieno-thiophene derivatives; heat treatment; improved solubility
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816532 Biphenyl compounds useful as muscarinic receptor antagonists
10/19/2010US7816529 Sodium and calcium channel antagonists; higher potency; fewer side effects to central nervous system
10/19/2010US7816476 dental adhesive, cement, filling, coating; radical polymerization reactivity comparable with methacrylates and little shrinkage during polymerization; bicyclo[3.1.0]hexane alkly acrylates; tricyclo[3.2.1.0-2,4]octane alkyl acrylates
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816357 Regulation of appetite, antiemetics, immunosuppression, analgesia, inflammation, antinocioception, sedation, and intraocular pressure; synergistic; 2-(4-(Trifluoromethyl)benzyl)-7,8-bis(4-chlorophenyl)-6-(methylamino)-[1,2,4]triazolo[4,3-b]pyridazin-3(2H)-one
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2463284C Pyrimidine compounds and pharmaceutical compositions containing the compounds
10/19/2010CA2437409C Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/19/2010CA2436526C Heterocyclic sulfonamide inhibitors of beta amyloid production
10/19/2010CA2271096C Trisresorcinyltriazines
10/19/2010CA2214338C Use of .alpha.1l agonists for treating urinary incontinence
10/14/2010WO2010118063A2 Therapeutic compositions and related methods of use
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
10/14/2010WO2010068720A3 Podophyllotoxin inhibitors of topoisomerase ii
10/14/2010US20100261900 Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates
10/14/2010US20100261899 Imidazole compounds
10/14/2010US20100261898 Imidazole compounds
10/14/2010US20100261761 Novel Sulfonylpyrroles
10/14/2010US20100261760 EP2 Receptor Agonists
10/14/2010US20100261727 2-arylbenzothiophene derivatives or pharceutically acceptable salts thereof, preparation method thereof, and pharceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as active ingredient
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100260778 Small-molecule botulinum toxin inhibitors
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2757640A1 Indole derivatives and methods for antiviral treatment
10/14/2010CA2757138A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010CA2756568A1 Kinase inhibitors and method of treating cancer with same
10/13/2010EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1204642B1 Fungicides
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861307A Certain substituted amides, method of making, and method of use thereof
10/13/2010CN101857591A Hydrochloric acid tiagabine crystal formations and preparation method thereof
10/13/2010CN101857588A 4-aromatic aminoquinazoline derivative and purpose thereof
10/13/2010CN101857587A 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient
10/13/2010CN101215284B Modified preparation method for eprosartan
10/13/2010CN101133036B Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
10/13/2010CN101081843B Non-nucleoside reverse transcriptase inhibitors
10/12/2010US7812170 Insecticides
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812031 Pyrimidine derivatives as orexin receptor antagonists
10/12/2010CA2477903C Substituted benzofurans useful as protein kinase b activators
10/12/2010CA2476164C Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity
10/12/2010CA2467838C Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i)
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010113986A1 Use of pyridazinone compound for control of harmful arthropod pests
10/07/2010WO2010113957A1 Pharmaceutical composition for treating or preventing glaucoma
10/07/2010WO2010113952A1 Muscarinic receptor antagonist
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010US20100256397 Water soluble photochromic compounds for labeling of biomolecules and method for detecting biomolecules using the same
10/07/2010US20100256376 Processes For Preparing Benzimidazole Thiophenes
10/07/2010US20100256170 Pyrazole compounds useful as protein kinase inhibitors
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256147 Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256138 Benzimidazole derivatives: preparation and pharmaceutical applications
10/07/2010US20100256097 Inhibitors of janus kinases
10/07/2010US20100252112 Semiconducting Compounds and Devices Incorporating Same
10/07/2010CA2757291A1 Medical composition for treatment or prophylaxis of glaucoma
10/07/2010CA2757188A1 Pyrimidine compound
10/06/2010EP2236508A1 Reactive Heterocycle-Substituted 7-Hydroxycoumarins and Their Conjugates
10/06/2010EP2236500A1 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
10/06/2010EP2236492A1 Novel dicarboxylic amino acid derivatives and the use thereof in the treatment of neurodegenerative diseases
10/06/2010EP2236137A1 Pharmaceutical composition for treatment of fatty liver diseases
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010CN101855214A Benzimidazole derivatives and their use as FXR agonists
10/06/2010CN101851231A Synthesis method of novel Taxotere derivative and application thereof in preparation of anti-tumor medicine
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 523